Stocks
Teva Pharmaceutical Industries (TEVA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 11.2 | 7.55 | 6.65 | 7.04 | 6.70 | 6.82 | ||
| Changes by years, y/y, % | -17% | -33% | -12% | +6% | -5% | -13.2% | |||
Teva Pharmaceutical Industries. EV/EBITDA
Teva Pharmaceutical Industries. EV/EBITDA, changes, %
Teva Pharmaceutical Industries (TEVA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | 6.99 | 7.59 | 7.97 | 6.68 | 7.45 | 6.82 | |
| Changes by years, y/y, % | -1% | +11% | +13% | -5% | +1% | |||
| Changes by quarters, q/q, % | -5% | +9% | +5% | -16% | +12% | |||
